SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410939-22-000059
Filing Date
2022-05-04
Accepted
2022-05-04 16:10:22
Documents
55
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q isee-20220331.htm   iXBRL 10-Q 1559654
2 EX-10.2 isee33122ex102amdendmentno.htm EX-10.2 14123
3 EX-31.1 isee33122exhibit311.htm EX-31.1 11457
4 EX-31.2 isee33122exhibit312.htm EX-31.2 11692
5 EX-32.1 isee33122exhibit321.htm EX-32.1 6492
6 EX-32.2 isee33122exhibit322.htm EX-32.2 6584
12 isee-20220331_g1.jpg GRAPHIC 146461
  Complete submission text file 0001410939-22-000059.txt   5765299

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT isee-20220331.xsd EX-101.SCH 33295
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT isee-20220331_cal.xml EX-101.CAL 35368
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT isee-20220331_def.xml EX-101.DEF 160054
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT isee-20220331_lab.xml EX-101.LAB 437401
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT isee-20220331_pre.xml EX-101.PRE 273454
49 EXTRACTED XBRL INSTANCE DOCUMENT isee-20220331_htm.xml XML 723631
Mailing Address 8 SYLVAN WAY PARSIPPANY NJ 07054
Business Address 8 SYLVAN WAY PARSIPPANY NJ 07054 (609) 474-6755
IVERIC bio, Inc. (Filer) CIK: 0001410939 (see all company filings)

IRS No.: 208185347 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36080 | Film No.: 22891597
SIC: 2834 Pharmaceutical Preparations